JB Chemicals & Pharmaceuticals Q1 Results Live : JB Chemicals & Pharmaceuticals declared their Q1 results on 08 Aug, 2024. The topline increased by 12.07% & the profit increased by 24.25% YoY. As compared to the previous quarter the revenue grew by 16.56% and the profit increased by 40.16%.
The Selling, general & administrative expenses rose by 9.31% q-o-q & increased by 12.21% Y-o-Y.
The operating income was up by 52.24% q-o-q & increased by 19.36% Y-o-Y.
The EPS is ₹11.16 for Q1 which increased by 23.04% Y-o-Y.
JB Chemicals & Pharmaceuticals has delivered 1.83% return in the last 1 week, 10.33% return in last 6 months and 19.88% YTD return.
Currently the JB Chemicals & Pharmaceuticals has a market cap of ₹30228.52 Cr and 52wk high/low of ₹2010 & ₹1244.45 respectively.
As of 09 Aug, 2024 out of 10 analysts covering the company, 1 analyst has given Sell rating, 2 analysts have given Hold rating, 2 analysts have given Buy rating & 5 analysts have given Strong Buy rating.
The consensus recommendation as on 09 Aug, 2024 was to Buy.
JB Chemicals & Pharmaceuticals Financials
Period | Q1 | Q4 | Q-o-Q Growth | Q1 | Y-o-Y Growth |
---|---|---|---|---|---|
Total Revenue | 1004.4 | 861.73 | +16.56% | 896.2 | +12.07% |
Selling/ General/ Admin Expenses Total | 166.91 | 152.7 | +9.31% | 148.75 | +12.21% |
Depreciation/ Amortization | 40.78 | 40.74 | +0.1% | 31.38 | +29.96% |
Total Operating Expense | 764.81 | 704.35 | +8.58% | 695.47 | +9.97% |
Operating Income | 239.59 | 157.38 | +52.24% | 200.73 | +19.36% |
Net Income Before Taxes | 239.84 | 164.6 | +45.71% | 194.3 | +23.44% |
Net Income | 176.83 | 126.16 | +40.16% | 142.32 | +24.25% |
Diluted Normalized EPS | 11.16 | 8.06 | +38.46% | 9.07 | +23.04% |
Catch all the Business News , Corporate news , Breaking News Events and Latest News Updates on Live Mint. Download The Mint News App to get Daily Market Updates.
MoreLess